ArticleThe Lancet. Oncology2023

Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma - Authors' reply.

Georgina V Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.